CML is a myeloproliferative neoplasm characterized by the t(9;22)(q34;q11) reciprocal chromosomal translocation that generates the bcr-abl fusion gene encoding a constitutive kinase activity which is necessary for CML pathogenesis [51]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.